Advertisement

The Latest

In this episode, Kevin Neese, MD, Co-owner, Helix Advanced Medicine, discusses building a prevention focused primary care model, improving healthspan, and using early risk detection to keep patients healthier and out of the hospital.

The FDA has approved Novo Nordisk’s Awiqli as the first once-weekly, long-acting basal insulin for children 10 years and older with Type 2 diabetes. Awiqli (insulin icodec-abae) injection, 700 units/milliliter, was approved as an adjunct to diet and exercise to…

Advertisement